Clinical trials
Prospective Study clinical trials
Below are recruiting prospective study clinical trials, each written for real people, not researchers. We’re tracking 879 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06720532Recruiting
Kidney function in men with prostate cancer getting a new targeted radiation therapy
This study looks at how a targeted radiation therapy called 177Lu-PSMA affects kidney function in men with a type of advanced prostate cancer. It aims to understand risk factors to help guide safe treatment.
MunichAges 18 years+ - NCT06721624Recruiting
Natural approaches for IBS: a research study
This study observes how naturopathic treatments help people with Irritable Bowel Syndrome (IBS) or IBS-like symptoms. It aims to understand what works in real-world care.
Portland, OregonAges 18 years+ - NCT06730113Recruiting
Young adults with type 2 diabetes and heart health study
This study looks at how type 2 diabetes starting in youth affects the heart over time. It also includes teens and young adults who are overweight or lean, and their biological parents, to compare heart health across these groups.
Washington D.C., District of ColumbiaAges 12–25 - NCT06741553Recruiting
Studying lecanemab for early Alzheimer's disease
This study looks at how well lecanemab works for people with early Alzheimer's disease. It aims to see if the drug can help slow down memory and thinking problems.
Hangzhou, ZhejiangAges Up to 85 years - NCT06758492Recruiting
Video vs direct laryngoscopy for surfactant in newborns
This study compares two ways of placing a thin tube into a newborn's windpipe to give surfactant—a medicine that helps their lungs work better. It will help doctors understand which method is safer and easier for babies needing this treatment.
RijekaAges birth–4 weeks - NCT06758648Recruiting
Eye blood vessels in Fabry disease
This study looks at the tiny blood vessels in the eyes of people with Fabry disease using a special camera. It may help doctors understand how the disease affects the eyes over time.
München, BavariaAges 18 years+ - NCT06760858Recruiting
Study of treatment for advanced stomach cancer
This study tests a treatment approach for stomach cancer that hasn't spread to other organs. It's for people who have not had any prior cancer treatments and are in relatively good health.
Chongqing, Chongqing MunicipalityAges 18–80 - NCT06774001Recruiting
Global study of appendectomy outcomes for appendicitis
This study follows people around the world who have their appendix removed for appendicitis. It aims to track outcomes and improve care for this common surgery.
CotonouAges Any age - NCT06781008Recruiting
Studying tick-borne diseases in Sweden
This study is looking at people who might have a tick-borne disease in Sweden. It aims to learn more about these illnesses and how they affect people.
Falun, Region DalarnaAges 1 year+ - NCT06782217Recruiting
Safety study of bee and wasp venom allergy shots
This study monitors the safety of venom immunotherapy (allergy shots) for people with bee or wasp sting allergies. If you are starting this treatment, researchers will track how well you tolerate it over time.
Ferrol, A CoruñaAges 14 years+ - NCT06785740Recruiting
Statins for older stroke patients with frailty
This study looks at how well statins work in older stroke or TIA patients who are already taking them and also have some frailty. The goal is to understand if continuing statins is safe and helpful for this group.
Almere StadAges 70–120 - NCT06791889Recruiting
Tracking bacteria in blood of ICU sepsis patients
This study uses a highly sensitive blood test (DdPCR) to quickly find and monitor harmful bacteria in ICU patients with sepsis, aiming to improve early detection and treatment.
WuhanAges 18 years+ - NCT06796725Recruiting
Study of TMS for migraine guided by brain imaging
This study tests whether repetitive transcranial magnetic stimulation (rTMS), guided by magnetoencephalography (MEG), can help people with frequent migraines or tension-type headaches. If you have headaches 15 or more days per month, this treatment might reduce your pain.
ShanghaiAges 15–50 - NCT06805474Recruiting
Study of a vision test for Stargardt and geographic atrophy
This study tests a new way to measure vision, called MLSDT, in people with normal sight or vision loss from Stargardt disease or geographic atrophy (a type of advanced age-related macular degeneration). Results will help doctors better understand how well patients can see.
Dallas, TexasAges 18 years+ - NCT06824909Recruiting
Faster pancreas tumor diagnosis with AI
This trial uses a new, faster method to diagnose solid pancreatic tumors during an endoscopic ultrasound procedure. It combines rapid staining of cells with artificial intelligence to give a quick and accurate diagnosis.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06833229Recruiting
Can a PET scan predict if immunotherapy is working?
This study uses a special PET-CT scan early in your treatment to see if immunotherapy (with or without chemotherapy) is working against your advanced lung cancer. The goal is to find out faster if the treatment is helping.
NiceAges 18 years+ - NCT06837454Recruiting
Study of eczema patients on systemic therapy
This study follows adults with moderate to severe eczema who are eligible for or already taking systemic (pill or injection) medicines. It does not test any new drug—it simply tracks how eczema is managed in real life, which may help improve future care.
Aix-en-ProvenceAges 18 years+ - NCT06844734Recruiting
Study of ITB treatment for hereditary spastic paraplegia
This trial tests if a treatment called ITB (intrathecal baclofen) can help reduce muscle stiffness in people with hereditary spastic paraplegia (HSP). Participants will receive the treatment and be followed over time to see how well it works.
Shanghai, Shanghai MunicipalityAges 14–70 - NCT06878131Recruiting
Precision-MRD: Targeted therapy study for colorectal cancer with MRD
This study looks at how well targeted therapies work for people with colorectal cancer who have minimal residual disease (MRD, tiny amounts of cancer left after treatment) detected by a blood test. It is for people who have a specific genetic change (biomarker) in their tumor and have not been treated with the targeted therapy for that biomarker before.
Houston, TexasAges 18 years+ - NCT06878625RecruitingPhase 2
Trop-2 drug combo for advanced triple-negative breast cancer
This trial tests a new drug combination (Trop-2 antibody-drug conjugate plus other therapies) for advanced triple-negative breast cancer that has spread or come back. It may offer a new option for people who have had only 1–2 prior chemotherapies and have not used immunotherapy or anti-angiogenic drugs before.
Tianjin, Tianjin MunicipalityAges 18–70 - NCT06895044Recruiting
How myopic children's eyes grow over time
This study follows how the eyes of children with nearsightedness (myopia) grow over time. It aims to learn more about how myopia changes as children get older.
ParisAges 6–17 - NCT06897293Recruiting
Tape Implant vs Standard Repair for Ankle Instability
This trial tests whether adding a special tape to a standard ankle ligament repair helps people with chronic ankle instability more than the standard repair alone. If you have loose joints and a history of ankle giving way, this study may be an option.
Beijing, Beijing MunicipalityAges 15–55 - NCT06936163Recruiting
Surgery for foot deformities in hereditary spastic paraplegia
This study looks at how well surgery works for foot problems like tight heel cords or clubfoot in people with hereditary spastic paraplegia (HSP), a condition that causes leg stiffness. It aims to see if surgery can improve walking, reduce pain, and prevent falls.
Shanghai, Shanghai MunicipalityAges 10–45 - NCT06938516Recruiting
Study of Nebilet for high blood pressure
This study is for people with high blood pressure who are taking or about to start the medication Nebilet. It will track how well Nebilet controls blood pressure in real-world settings, including people with other heart conditions.
Semarang, Central JavaAges 18–100
Hear when a new Prospective Study trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for prospective study?
- Yes. Clin2 currently lists 879 recruiting prospective study studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a prospective study trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a prospective study trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.